Reactional states in multibacillary hansen disease patients during multidrug therapy

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 40, Issue 6, 1998, Pages 363-370

  Nery, José A C ^a   Vieira, Leila M M ^b   De Matos, Haroldo J ^b   Gallo, Maria E N ^a   Sarno, Euzenir N ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

ENL; Leprosy; Leprosy reactions; MDT; Reversal reaction

Indexed keywords

CLOFAZIMINE; DAPSONE; LEPROSTATIC AGENT; RIFAMPICIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG COMBINATION; ERYTHEMA NODOSUM; FEMALE; FOLLOW UP; HUMAN; LEPROMATOUS LEPROSY; LEPROSY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RECURRENT DISEASE; RISK FACTOR;

ADOLESCENT; ADULT; AGED; CHILD; CLOFAZIMINE; COHORT STUDIES; DAPSONE; DRUG THERAPY, COMBINATION; ERYTHEMA NODOSUM; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEPROSTATIC AGENTS; LEPROSY; LEPROSY, LEPROMATOUS; MALE; MIDDLE AGED; RECURRENCE; RIFAMPIN; RISK FACTORS;

EID: 0032199925     PISSN: 00364665     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0036-46651998000600005     Document Type: Article

References (25)

1. BECX-BLEUMINCK, M. & BERHE, D. - Occurrence of reactions their diagnosis and management in leprosy patients treated with multidrug therapy experience in the leprosy control program of the All Africa leprosy and Rehabilitation Training Centre (ALERT) in Ethiopia. Int. J. Leprosy, 60: 173-184, 1992.
2. BWIRE, R. & KAWUMA, H.J.S. - Hospital-based epidemiological study of reactions, Buluba Hospital, 1985-89. Leprosy Rev., 64: 325-329, 1993.
3. CAMPOS, N.S. & DE SOUZA, P.R. - Reactional states in leprosy. Int. J. Leprosy, 22: 259-264, 1954.
4. DEAN, A.G.; DEAN, J.A. & DICKER, R.C. - Epi Info, Version 6.03: a word processing, database, and statistics program for epidemiology on microcomputers. Stone Mountain, Georgia, USD, Inc., 1996.
5. GALLO, M.E.N.; ALVIM, M.F.S.; NERY, J.A.C.; ALBUQUERQUE, E.C.A. & SARNO, E.N. - Two multidrug fixed-dosage treatment regimens with multibacillary leprosy patients. Indian J. Leprosy, 68: 235-245, 1996.
6. GROENEN, G.; JANSSENS, L.; KAYEMBE, T. et al. - Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions. Int. J. Leprosy, 54: 236-244, 1986.
7. GUINTO, R.S.; TOLENTINO, I.G. & MALABAY, M.C. - Observations on erythema nodosum leprosum: clinical evaluations studies in lepromatous leprosy. Int. J. Leprosy, 31: 81-94, 1963.
8. LIENHARDT, C. & FINE, P.E.M. - Type 1 reaction, neuritis and disability in leprosy. What is the current epidemiological situation ? Leprosy Rev., 65: 9-33, 1994.
9. LOCKWOOD, D.J.; VINAYAKUMAR, S.; STANLEY, J.N.A.; MCADAM, K.P.W.J. & COLSTON, M.J. - Clinical features and outcome of reversal (Type 1) reactions in Hyderabad, India. Int. J. Leprosy, 61: 8-15, 1993.
10. NAAFS, B. & WHEATE, H.W. - The time interval between the start of antileprosy treatment and the development of reactions in borderline patients. Leprosy Rev., 49: 153-157, 1978.
11. NAAFS, B.; PEARSON, J.M.H. & WHEATE, H.W. - Reversal reaction: the prevention of permanent nerve damage. Comparison of short and long-term steroid treatment. Int. J. Leprosy, 47: 7-12, 1979.
12. PFALTZGRAFF, R.E. - The management of reaction in leprosy. Int. J. Leprosy, 57: 103-109, 1989.
13. RAMU, G. - Management of reactions in leprosy. J. Indian med. Ass., 61: 403-406, 1973.
14. RIDDLEY, D.S. - Bacterial indices. In: COCHRANE, R.G.; DAVEY, T.F. & McROBERT, G., ed. Leprosy in theory and practice. 2. ed Bristol, John Wright, 1964. p. 620-621.
15. RIDLEY, D.S & JOPLING, W.H. - Classification of leprosy according to immunity. A five group system. Int. J. Leprosy, 34: 255-273, 1966.
16. RIDLEY, D.S. & WATERS, M.F. - Significance of variations within the lepromatous group. Leprosy. Rev., 40: 143-152, 1969.
17. ROSE, P. & WATERS, M.F.R. - Reversal reactions in leprosy and their management. Leprosy Rev, 62: 113-119, 1991.
18. SCOLLARD, D.M.; SMITH, T.; BHOOPAT, L., et al. - Epidemiologic characteristics of leprosy reactions. Int. J. Leprosy, 62: 559-567, 1994.
19. SEHGAL, V.N. - Reactions in leprosy: clinical aspects. J. Derm., 26: 278-285, 1987.
20. SKINSNES, O.K. - The immunological spectrum of leprosy. In : COCHRANE, R.G.; DAVEY, T.F. & McROBERT, G., ed Leprosy in theory and practice. Bristol, John Wright, 1959. p. 156-182.
21. SRINIVASAN, H. - Deformities and disabilities: unfinished agenda in leprosy work. Leprosy Rev., 66: 193-200, 1995.
22. VAN BRAKEL, W.H.; SOLDENHOFF, R. & McDOUGALL, A.C. - The allocation of leprosy patients into paucibacillary and multibacillary groups for multidrug therapy, taking into account the number of body areas affected by skin, or skin and nerve lesions. Leprosy Rev., 63: 231-246, 1992.
23. VIEIRA, L.M.M.; SAMPAIO, E.P.; NERY, J.A.C. et al. - Immunological status of ENL (erythema nodosum leprosum) patients: its relationship to bacterial load and levels of circulating IL-2R. Rev. Inst. Med. trop. S. Paulo, 38: 103-111, 1996.
24. WORLD HEALTH ORGANIZATION - Comité de Expertos de la OMS en Lepra. Quinto Informe. Org. mund Salud Ser. Inf. téc., (607), 1977.
25. WORLD HEALTH ORGANIZATION - Report of a WHO Study Group on Chemotherapy of Leprosy. Geneva, 1993.